|本期目录/Table of Contents|

[1]王黔宇,王 云,蒋 婷,等.微波消融和冷冻消融治疗肺结节有效性及安全性对比分析[J].中华肺部疾病杂志,2024,(06):980-984.[doi:10.3877/cma.j.issn.1674-6902.2024.06.024
]
点击复制

微波消融和冷冻消融治疗肺结节有效性及安全性对比分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2024年06期
页码:
980-984
栏目:
临床研究
出版日期:
2024-12-25

文章信息/Info

Title:
-
作者:
王黔宇; 王 云; 蒋 婷; 杨 芳; 廖江荣
563003 遵义,贵州航天医院呼吸与危重症医学科
Author(s):
-
关键词:
肺结节;  微波消融;  冷冻消融检;  有效性;  安全性
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2024.06.024
摘要:
目的 分析CT引导下微波消融和冷冻消融治疗肺结节有效性及安全性。方法 选择2018年7月至2022年7月我院收治的肺结节患者41例,微波消融治疗24 例为微波组,冷冻消融治疗17例为冷冻组。比较两组治疗后并发症、无进展生存率。结果 微波组肿瘤部位左侧11 例(45.83%)、右侧13例(54.17%),肿瘤大小<3.0 cm 13例(54.17%)、3.1～5.0 cm 1例(4.17%)、5.1～7.0 cm 1例(4.17%)、>7.0 cm 9例(37.50%)、病理类型良性7例(29.17%)、肺鳞癌2例(8.33%)、肺腺癌15例(62.50%),TNM分期无10例(41.67%)、Ⅰ期8例(33.33%)、Ⅱ期0例、Ⅲ期0例、Ⅳ期6例(25.00%); 冷冻组肿瘤部位左侧5例(29.41%)、右侧12例(70.59%),肿瘤大小<3.0 cm 3例(17.65%)、3.1～5.0 cm 1例(5.88%)、5.1～7.0 cm 0例(0.00%)、>7.0 cm 13例(76.47%)、病理类型良性10例(58.82%)、肺鳞癌1例(5.88%)、肺腺癌6例(35.29%),TNM分期无13例(76.47%)、Ⅰ期2例(11.77%)、Ⅱ期1例(5.88%)、Ⅲ期0例、Ⅳ期1例(5.88%)(P>0.05)。微波组气胸5 例(20.83%)、胸腔积液2例(8.33%)、复发3例(12.5%)和远处转移1例(4.17%); 冷冻组气胸3例(17.65%)、胸腔积液0例、复发1例(5.88%)和远处转移1例(5.88%)。微波组治疗6个月后复发2例(8.33%),治疗1年后复发1例(4.17%),复发者2年内死亡。冷冻组2年内无复发。结论 微波消融及冷冻消融对肺结节治疗安全有效,可作为除手术之外肺结节治疗选择方式。
Abstract:
-

参考文献/References:

1 Ettinger DS, Wood DE, Aisner DL, et al. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(5): 497-530.
2 Sarajlic V, Vesnic S, Udovicic-Gagula D, et al. Diagnostic accuracy and complication rates of percutaneous CTguided coaxial needle biopsy of pulmonary lesions[J]. Di-agn Interv Radiol, 2021, 27(4): 553-557.
3 国家卫生健康委员会医疗应急司. 肺癌筛查与早诊早治方案(2024年版)[J]. 中华肿瘤杂志, 2024, 46(10): 911-912.
4 Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer J Clin, 2021, 71(3): 209-249.
5 Rangamuwa K, Leong T, Weeden C, et al.Thermal ablation in non-small cell lung cancer: A review of treatment modalities and the evidence for combination withimmune checkpoint inhibitors[J]. Transl Lung Cancer Res, 2021, 10(6): 2842-2857.
6 中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2018 年版)[J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.
7 Kong F, Wang C, Li Y, et al. Advances in study of the sequence of lung tumor biopsy and thermal ablation [J]. Thorac Cancer, 2021, 12(3): 279-286.
8 雷光焰, 张 艰, 閆小龙. 肺结节诊治西北地区专家共识(2021年版)[J]. 中国医药科学, 2021, 11(23): 16-22.
9 Kong F, Bie Z, Li Y, et al. Synchronous microwave abla-tion followed by core-needle biopsy via a coaxial cannu-la for highly suspected malignant lung ground-glassopacities: A single-center, single-arm retrospective studyo[J]. Thorac Cancer, 2021, 12(23): 3216-3222.
10 叶 欣, 范卫君, 王忠敏, 等. 热消融治疗肺部亚实性结节专家共识(2021年版)[J]. 中国肺癌杂志, 2021, 24(5): 305-322.
11 郭兰坤, 肖越勇, 魏颖恬, 等. CT引导下肺结节热消融联合术中即时活检的可行性[J]. 中国介入影像与治疗学, 2022, 19(3): 129-133.
12 吴 航, 杨维建. 冷冻消融治疗肺癌的免疫反应及其增强机制的研究探析[J]. 甘肃科技, 2023, 39(4): 72-75.
13 Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 [J]. Chin Med J(Engl), 2021, 134(7): 783-791.
14 张馨元, 周 翔. 肺癌的消融治疗[J]. 中国医刊, 2020, 55(5): 475-477.
15 Wang L, Xu J, Yu J, et al. Review of clinical tumor ablation advance in Asia [J]. Int J Hyperthermia, 2021, 38(1): 1639-1649.
16 张晓菊, 白 莉, 金发光, 等. 肺结节诊治中国专家共识(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.
17 Zhang H, Tian S, Wang S, et al. CT-guided percutaneous core needle biopsy in typing and subtyping lung cancer:A comparison to surgery[J]. Technol Cancer Res Treat, 2022, 21: 15330338221086411.
18 Yang L, Wang Y, Li L, et al. C-arm cone-beam CT virtu-al Navigation versus conventional CT guidance in the transthoracic lung biopsy: A case-control study[J]. Diag-nostics(Basel), 2022, 12(1): 115.
19 高 飞, 韩旭建, 窦卫涛, 等. CT引导经同轴套管微波消融同步穿刺活检肺高度可疑恶性磨玻璃结节[J]. 中国介入影像与治疗学, 2020, 17(8): 464-467.
20 Chen C, Xu L, Sun X, et al. Safety and diagnostic accura-cy of percutaneous CT-guided transthoracic biopsy of small lung nodules(≤20 mm)adjacent to the pericardi-um or great vessels[J].Diagn Interv Radiol, 2021, 27(1): 94-101.
21 Ni Y, Xu H, Ye X. Image-guided percutaneous microwave-ablation of early-stage non-small cell lung cancer[J]. Asia Pac J Clin Oncol, 2020, 16(6): 320-325.
22 Laeseke P, Ng C, Ferko N, et al. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis[J]. Lung Cancer, 2023, 182: 107259.
23 Chan MV, Huo YR, Cao C, et al. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer(NSCLC): a systematic review and meta-analysis[J]. Eur Radiol, 2021, 31(7): 5421-5433.
24 Wang Y, Liu B, Cao P, et al. Comparison between computed tomography-guided percutaneous microwave ablation and thoracoscopic lobectomy for stage I non-small cell lung cancer[J]. Thorac Cancer, 2018, 9(11): 1376-1382.
25 Yang X, Jin Y, Lin Z, et al. Microwave ablation for the treatment of peripheral ground-glass nodule-like lung cancer: Long-term results from a multi-center study[J]. J Cancer Res Ther, 2023, 19(4): 1001-1010.
26 Wei Z, Yang X, Wu J, et al. SPACES: Our team's experience in lung tumor microwave ablation[J]. J Cancer Res Ther, 2023, 19(1): 1-13.
27 Ye X, Fan WJ, Wang ZM, et al. Clinical practice guide lines on image-guided thermal ablation of primary and metastatic lung tumors(2022 edition)[J]. J Cancer Res Ther, 2022, 18(5): 1213-1230.
28 Tian Y, Qi X, Jiang X, et al. Cryoablation and immune synergistic effect for lung cancer: A review[J]. Front Immunol, 2022, 13: 950921.
29 Xu Z, Wang X, Ke H, et al. Cryoablation is superior to radiofrequency ablation for the treatment of non-small cell lung cancer: A meta-analysis[J]. Cryobiology, 2023, 112: 104560.
30 Liu S, Liang B, Li Y, et al. CT-guided percutaneous cryoablation in patients with lung nodules mainly composed of ground-glass opacities[J]. J Vasc Interv Radiol, 2022, 33(8): 942-948.
31 Yamauchi Y, Izumi Y, Hashimoto K, et al. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer[J]. PLoS One, 2012, 7(3): e33223.
32 Das SK, Huang YY, Li B, et al. Comparing cryoablation and microwave ablation for the treatment of patients with stage ⅢB/Ⅳ non-small cell lung cancer[J]. Oncol Lett, 2020, 19(1): 1031-1041.
33 Wei Z, Ye X, Yang X, et al. Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: a retrospective study[J]. Int J Hyperthermia, 2019, 36(1): 827-834.
34 姜 华, 金发光. 肺小结节消融的现状与争议[J/CD]. 中华肺部疾病杂志(电子版), 2024, 17(3): 493-496.
35 任茂玲, 孙晓容, 何晓丽. CT引导下射频消融术在肺部磨玻璃结节诊断中的应用及术后并发症的危险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(5): 718-720.

备注/Memo

备注/Memo:
基金项目: 贵州省科技厅项目(黔科合成果-LC[2024]062)
遵义市科技局项目(遵市科合HZ字[2023]444)
贵州省卫健委(gzwkj2024-334)
通信作者: 廖江荣, Email: ljr3409@sina.com
更新日期/Last Update: 2024-12-25